Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | XENE | APLS | ||
| Company | Crispr Therapeutics Ag | Xenon Pharmaceuticals Inc | Apellis Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 53.05 | 56.13 | 41.02 | ||
| High | 55.85 | 57.47 | 41.05 | ||
| Low | 52.55 | 55.73 | 41.00 | ||
| Latest | 54.83 | 56.44 | 41.03 | ||
| Change | +2.41 | +0.44 | +0.02 | ||
| % Change | +4.60% | +0.79% | +0.05% | ||
| Volume | 1,733,400 | 920,500 | 7,067,400 | ||
| 20-Day Average Volume | 1,936,635 | 920,885 | 3,905,450 | ||
| Previous Close | 52.42 | 56.00 | 41.01 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.09 | 56.93 | 40.94 | ||
| 20-Day Raw Stochastic | 57.06% | 46.94% | 75.00% | ||
| 20-Day Relative Strength | 53.28 | 53.28 | 82.00 | ||
| Weighted Alpha | +35.57 | +52.72 | +26.49 | ||
| Today's Opinion | 16% Sell | 80% Buy | 100% Buy | ||
| Previous Opinion | 48% Sell | 80% Buy | 100% Buy | ||
| Last Month's Opinion | 72% Sell | 100% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.20% since 05/01/26 | +0.55% since 05/01/26 | +0.17% since 05/01/26 | ||
| Low | 49.38 on 05/05/26 | 55.73 on 05/08/26 | 40.93 on 05/05/26 | ||
| High | 55.85 on 05/08/26 | 58.85 on 05/06/26 | 41.14 on 05/06/26 | ||
| 1-Month | |||||
| %Chg | +5.93% since 04/08/26 | -1.91% since 04/08/26 | +0.84% since 04/08/26 | ||
| Low | 48.77 on 04/24/26 | 53.30 on 04/28/26 | 40.64 on 04/09/26 | ||
| High | 59.39 on 04/15/26 | 59.99 on 04/14/26 | 41.14 on 05/06/26 | ||
| 3-Month | |||||
| %Chg | +12.49% since 02/06/26 | +36.39% since 02/06/26 | +74.67% since 02/06/26 | ||
| Low | 44.12 on 03/30/26 | 40.74 on 02/11/26 | 16.83 on 03/30/26 | ||
| High | 61.76 on 02/26/26 | 63.95 on 03/10/26 | 41.14 on 05/06/26 | ||
| 6-Month | |||||
| %Chg | -0.53% since 11/07/25 | +47.56% since 11/07/25 | +113.03% since 11/07/25 | ||
| Low | 44.12 on 03/30/26 | 37.72 on 11/11/25 | 16.83 on 03/30/26 | ||
| High | 61.76 on 02/26/26 | 63.95 on 03/10/26 | 41.14 on 05/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,288,298 | 5,454,530 | 5,252,701 | ||
| Shares Outstanding, K | 96,449 | 96,643 | 128,021 | ||
| Annual Sales | 3,510,000 | 7,500,000 | 1,003,780,000 | ||
| Annual Net Income | -581,600,000 | -345,910,000 | 22,390,000 | ||
| Last Quarter Sales | 860,000 | 0 | 199,910,000 | ||
| Last Quarter Net Income | -130,610,000 | -105,260,000 | -58,950,000 | ||
| 60-Month Beta | 1.74 | 0.65 | -0.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.28 on 05/04/26 | -1.17 on 05/07/26 | -0.47 on 02/24/26 | ||
| Earnings Date | 08/03/26 | 08/10/26 | 07/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 40.21 | ||